Literature DB >> 12514144

Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy.

Andrew Y C Wong1, Michael G Irwin, Theresa W C Hui, Serena K Y Fung, S T Fan, Edmond S K Ma.   

Abstract

PURPOSE: To determine the effects of desmopressin on coagulation and blood loss in patients undergoing elective partial hepatectomy.
METHODS: A randomized, controlled and double-blind study on 59 patients who received either 0.3 micro g x kg(-1) of desmopressin or an equal volume of normal saline (control) infused intravenously over 20 min after induction of general anesthesia.
RESULTS: There was an increase in plasma levels of factors VIII and von Willebrand after the infusion of study drug in both groups (P < 0.001). The activated partial thromboplastin time was shortened in Group D whereas prothrombin time was prolonged in Group C; (P = 0.02). A large range of intraoperative blood loss (400-7128 mL) was observed, with no significant differences between groups. There were no changes in plasma electrolyte levels or osmolality. Transfusion requirements were similar in both groups.
CONCLUSION: Desmopressin did not reduce intraoperative blood loss or transfusion requirements during hepatectomy despite raising clotting factor levels and improving tests of hemostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514144     DOI: 10.1007/BF03020180

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

Review 1.  Desmopressin for minimising perioperative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; A J Moxey; D O'Connell; B McClelland; K M Henderson; K Sly; A Laupacis; D Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 2.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  New concepts of coagulation and bleeding in liver disease.

Authors:  Patrick G Northup; Stephen H Caldwell
Journal:  Intern Emerg Med       Date:  2010-02       Impact factor: 3.397

Review 4.  Methods to decrease blood loss during liver resection: a network meta-analysis.

Authors:  Elisabetta Moggia; Benjamin Rouse; Constantinos Simillis; Tianjing Li; Jessica Vaughan; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-10-31

Review 5.  Coagulopathy in liver disease: Lack of an assessment tool.

Authors:  Annabel Blasi
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 6.  Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged.

Authors:  Armando Tripodi; Massimo Primignani; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2009-08-28       Impact factor: 3.397

7.  Anesthetic Considerations in Hepatectomies under Hepatic Vascular Control.

Authors:  Aliki Tympa; Kassiani Theodoraki; Athanassia Tsaroucha; Nikolaos Arkadopoulos; Ioannis Vassiliou; Vassilios Smyrniotis
Journal:  HPB Surg       Date:  2012-05-28

Review 8.  Desmopressin use for minimising perioperative blood transfusion.

Authors:  Michael J Desborough; Kathryn Oakland; Charlotte Brierley; Sean Bennett; Carolyn Doree; Marialena Trivella; Sally Hopewell; Simon J Stanworth; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-10

9.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

10.  Coagulopathy in liver disease.

Authors:  Wojciech Blonski; Timothy Siropaides; K Rajender Reddy
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.